Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD79B is a crucial component of the B-cell antigen receptor (BCR) complex. It forms a heterodimer with CD79A, which then associates with surface immunoglobulin to form the functional BCR on B lymphocytes. This complex initiates intracellular signaling upon antigen binding, essential for B cell development, activation, and immune response. Mutations in CD79B are associated with agammaglobulinemia, and specific mutations serve as biomarkers in lymphoma.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD79b molecule (CD79B).